Skip to content
Search

Latest Stories

Self-Care Strategy Group calls for expansion of prescribing rights

Self-Care Strategy Group calls for expansion of prescribing rights

The Group urges Wes Streetingto maximise self-care benefitsto strengthen NHS and reduce pressure on GPs

The Self-Care Strategy Group (SCSG), comprising of leading pharmacy groups, professional organisations, trade associations and charities committed to self-care, has written to Wes Streeting MP, Secretary of State for Health and Social Care, urging the government to fully realise the benefits of self-care and work collaboratively to build an NHS fit for the future.

In its letter, the SCSG has outlined several key proposals including:


  • Expansion of prescribing rights.
  • Optimisation of digital health tools such as the NHS App.
  • Enabling direct referrals between primary, diagnostic and specialist care services
  • Widening access to self-care medicines in pharmacies.
  • Training Primary Care Network (PCN) staff to support patients in navigating the care system.
  • Promoting credible health information on self-care and expanding public awareness campaigns

Dr Graham Jackson, a GP and Chair of SCSG, expressed concerns over the unprecedented pressures on the NHS and primary care, cautioning that these challenges are likely to increase without urgent action.

He emphasised the importance of collaborating with the Health Secretary and the government to unleash the full benefits of selfcare and build an NHS fit for the future.

The letter reads: “As you will be aware, self-care for minor and self-treatable conditions is a vital tool in managing capacity within primary and emergency care settings.

“With the NHS requiring significant investment to reduce waiting lists, improve diagnostic capacity and tackle the workforce crisis, cost-efficient means of relieving capacity in GP practices and A&E departments, as well as across primary care, are clearly needed.

“Self-care offers one solution to this problem, enabling systemic change to the UK’s approach to healthcare, including in deprived and rural communities.”

In 2021, the Self-Care Strategy Group released a comprehensive blueprint for a national self-care strategy, which included nine recommendations aimed at enhancing support and promotion of self-care in England.

The recommendations range from improving health literacy in the school curriculum and modernising digital health infrastructure to empowering pharmacists and widening patient access to self-care medicines through reclassification.

The Group has welcomed the NHS's progress in implementing self-care policies that improved access to pharmacy and primary care navigation. However, they noted that there is still significant potential to fully capitalize on the benefits of self-care.

“In line with your manifesto commitments, we believe opportunities exist to expand prescribing rights, optimise digital health tools (such as the NHS App), and enable direct referrals between primary, diagnostic and specialist care services – but also that there is potential to go further.

“By widening access to self-care medicines in pharmacies, training Primary Care Network (PCN) staff to support patients in navigating the care system, promoting credible health information and expanding public awareness campaigns, the benefits of self-care could be fully realised,” they wrote.

The group sought the opportunity to meet with Streeting to discuss how self-care can assist the government in alleviating pressure on GPs and A&E departments and serve as the foundation for a future-ready NHS.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less